Overview

Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This randomized phase I trial studies the side effects and best dose of defined green tea catechin extract in treating women with hormone receptor-negative stage I-III breast cancer. Green tea extract contains ingredients that may prevent or slow the growth of breast cancer.
Phase:
Phase 1
Details
Lead Sponsor:
National Cancer Institute (NCI)
Collaborator:
National Institutes of Health (NIH)
Treatments:
Epigallocatechin gallate
Hormones